- Research works
- 6 ▲ 5% vs 2013–17
- Citations
- 46 7.2 per fractional work
- Top-10% rate
- 25.5% record average 16.5%
- Open access
- 51% world 28%
Not ranked overall: Immunovia (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Immunovia (Sweden) publish most on?
By volume in 2022–2025: Pancreatic and Hepatic Oncology Research, Pancreatitis Pathology and Treatment, Cancer Genomics and Diagnostics and Diet and metabolism studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pancreatic and Hepatic Oncology Research Oncology 2 works
- 2 Pancreatitis Pathology and Treatment Surgery 0 works
- 3 Cancer Genomics and Diagnostics Cancer Research 0 works
- 4 Diet and metabolism studies Physiology 0 works
- 5 Adipose Tissue and Metabolism Physiology 0 works
- 6 Liver Disease Diagnosis and Treatment Epidemiology 0 works
- 7 Immunotherapy and Immune Responses Immunology 0 works
- 8 Lung Cancer Research Studies Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Immunovia (Sweden)'s research output changed?
Output in 2018–2022 was 5% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lund
- Lund University
- Skåne University Hospital
- MAX IV Laboratory
- European Spallation Source
- Lund Science (Sweden)
- Informa (Sweden)
- Swedish Institute for Health Economics
- Ideon Science Park
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.